Drawing for INGENIX PHARMACEUTICAL SERVICES

USPTO serial 76125209

INGENIX PHARMACEUTICAL SERVICES

Reviewed by CopyMark Law Group

Reg. 2676239Status 710
Filing date
Status date
Registration date
Jan 21, 2003
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INGENIX PHARMACEUTICAL SERVICES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

TIMOTHY M KENNY

TIMOTHY M KENNY FULBRIGHT & JAWORSKI LLP600 CONGRESS AVE STE 2400AUSTIN, TX 78701UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Management Services of a Business Nature for Clinical Trials in the Field of Investigational Drugs, Namely, Arranging for Sites to Perform Clinical Trials, Arranging for the Import, Packaging, Shipping, Labeling and Distribution of Drugs and Other Investigational Supplies to and from the Clinical Trial Sites, Arranging for the Central Collection of Laboratory Specimens from Clinical Trial Sites, Making Any and All Filings Required by the Food and Drug Administration for Investigational New Drugs, Preparing Statistical Reports Resulting from Clinical TrialsSECTION 8 - CANCELLEDJul 5, 2000
041Training Clinical Trial Site Personnel in the Use of Tests and Rating Systems for Drug Protocol Requirements; and Training Clinical Trial Site Personnel in the Use of Medical and Research Equipment Required by Drug ProtocolsSECTION 8 - CANCELLEDJul 5, 2000
042Management Services of a Scientific and Technical Nature for Clinical Trials in the Field of Investigational Drugs, Namely, Conducting Clinical Protocols and Trials for Others; Consulting Services Regarding Scientific and Technical Aspects of Clinical Trials of Investigational Drugs, Namely, Advising Others on Conducting Clinical Protocols and Trials and the Regulatory Requirements of the Food And Drug Administration; Technical Writing for Others of Clinical Report Forms Which Are Required by Clinical Trial Drug Protocols; Technical Writing for Others of Clinical Trial Reports; Database Development Services to Process Data Collected from Clinical TrialsSECTION 8 - CANCELLEDJul 5, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 29, 2009C8..CANCELLED SEC. 8 (6-YR)—
Jan 31, 2008CFITCASE FILE IN TICRS—
Jan 21, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 2002NPUBNOTICE OF PUBLICATION—
Jul 22, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2002MAILPAPER RECEIVED—
Jun 13, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2002MAILPAPER RECEIVED—
Dec 19, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 10, 2001DOCKASSIGNED TO EXAMINER—
Aug 16, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 16, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2001DOCKASSIGNED TO EXAMINER—
Jan 24, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance